*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Identifying gene clusters as signature biomarkers for predicting methotrexate effectiveness and potential side effects during Rheumatoid Arthritis therapy

Author: ANAS KHALEEL, AFNAN MEQBEL, ROWAN ALEJIELAT, YAZAN S. BATARSEH, ABDALLAH A. ELBAKKOUSH, BAYAN Y. GHANIM, CRISTINA I. BATARSEH, NIDAL A. QINNA
Abstract: Background: Analysis of gene expression based on primary experimental databases is a powerful systematic biological tool that can be implemented to facilitate the understanding of therapy prognosis and potential molecular interactions. Such an approach was adopted in the current research to explore key genes and functional relationships rising during clinical Rheumatoid Arthritis (RA) therapy by Methotrexate (MTX). Methods: The whole gene expression data GSE45867 from synovial biopsies of RA patients before and after MTX therapy was obtained from the Gene Expression Omnibus (GEO) database in The National Center for Biotechnology Information (NCBI). Gene clusters and biological characterizations were identified by Gene set enrichment analysis (GSEA) tool while co-expression genes and key molecular pathways of interaction were confirmed via Gene Multiple Association Network Integration Algorithm (GeneMANIA), The Search Tool for The Retrieval of Interacting Genes (STRING) and Reactome bioinformatics tools. Results: Data showed that MTX-treated RA patients had differentially expressed genes that are involved in MAPK kinase activation and Toll-like receptor pathways. Two distinct networks were discovered by the STRING database; a cluster of genes including STON2, ARRB1, CNKSR2, DLG3, FAT3, VANGL2 and another including NFIX, JUN, MAP3K8, APAF1, NAIP. Analysis of differentially expressed genes initiated by MTX treatment revealed significant gene clusters and networks that are involved in important inflammatory pathways. Conclusion: Such pathways and networks might serve as prognostic biomarkers for RA and can be further developed as predictive gene signatures for MTX activity and adverse effects.
Keyword: Gene networks; Bioinformatics; Synoviocyte; Rheumatoid
DOI: https://doi.org/10.31838/ijpr/2021.13.01.319
Download: Request For Article
 
Clients

Clients

Clients

Clients

Clients
ONLINE SUBMISSION
USER LOGIN
Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free